Cumberland Pharmaceuticals Inc (CPIX): Forecast Levels Chart

Corporate company logo of Cumberland Pharmaceuticals Inc (CPIX)

Cumberland Pharmaceuticals (CPIX) faces threats from a limited pipeline of new developments, patent disputes, and pressure from affordable alternatives. The company relies on the supply of emergency antidotes to hospitals, which ensures revenue stability. This price chart illustrates the asset's dynamics, where the current value is 9.80. Meanwhile, clinic budget limits constrain the ability to significantly increase drug pricing.

Cumberland Pharmaceuticals Inc (CPIX): Consensus Target from 07/04/2022 to 11/11/2026

Analytical breakdowns for Cumberland Pharma (CPIX)

- market price and analyst price targets:
- stock exchange capitalization data:
General company analysis:CPIX cumberlandpharma.com
Flagship merchandise of Cumberland Corp

To assess the fundamental value of Cumberland Pharmaceuticals (CPIX), an investor must compare current quotes with the fair valuation range of the business, which forms the consensus price target. This indicator aggregates the target values of leading analysts to determine the equilibrium point between supply and demand, which is critical when analyzing the expansion of Cumberland Pharmaceuticals through M&A and the broadening of its hospital drug portfolio.

Competitors of Cumberland Pharmaceuticals

Consensus Target haleon.com HLN|Price Target Chart Kenvue KVUE|VRNA (Verona Pharma PLC) - Forecast Levels Chart|Jyong Biotech Corp - Analyst Consensus Forecast|Analyst Median Target Ligand Corp LGND|AMRX (Amneal Pharmaceuticals) - Consensus Target|Broker Consensus Forecast PRGO|Price Target Chart Alvotech SA|Liquidia Corp - Forecast Levels Chart|Analyst Consensus Forecast GLPG|ANIP (ANI Pharmaceuticals Corp) - Fair Value Consensus|Analyst Consensus Forecast MNKD (MannKind Corporation)|Analyst Consensus Forecast amphastar.com AMPH|PCRX - Price Target Chart|Fair Value Consensus SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Price Target Chart|Consensus Target Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Tectonic|Consensus Target TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Fair Value Consensus|Price Target Chart Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Average Forecast Price|EXOZ: Consensus Target|Oramed Pharmaceuticals - Analyst Forecast Prices|ENTX: Analyst Consensus Forecast|MindWalk Holdings, Inc. - Fair Value Consensus|ABVC (ABVC BioPharma Inc) - Analyst Consensus Forecast|Average Forecast Price Quantum BioPharma Corp QNTM|Price Target Chart FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Fair Value Consensus|Analyst Consensus Forecast RANI (Rani Therapeutics Holdings, Inc.)|SNYR - Consensus Target|RLYB: Consensus Target|LEXX - Analyst Consensus Forecast|Pulmatrix, Inc. (PULM) - Price Target Chart|Consensus Target Pheton Holdings|APM (Aptorum Group Ltd) - Analyst Consensus Forecast|Price Target Chart LYRA|Analyst Consensus Forecast IBO|TNFA - Average Forecast Price|Price Target Chart cbdMD YCBD|Fair Value Consensus PRFX|CYTO - Price Target Chart|LIPO: Price Target Chart|OPTN: Analyst Consensus Forecast|Pieris Pharma (PIRS) - Analyst Consensus Forecast|Price Target Chart Procaps Group S.A.|Broker Consensus Forecast PTPI (petrospharma.com)|Analyst Consensus Forecast QLI|Acelyrin Inc. - Broker Consensus Forecast|TFF Pharma - Consensus Target